EUVIMEDEUVIMED entdecken
Crossref

Fgl-1 promotes the progression of endometrial adenocarcinoma through PI3K/AKT signal pathway

Wenjing Sun, Weijia Kong, Xinyu Yu, Kaiyue Shang, Qianqian Li, Hui Zhang

Medical Oncology · 2026

DOI: 10.1007/s12032-026-03375-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Wenjing Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Adenocarcinoma. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial adenocarcinoma (EAC) represents a prevalent malignancy of the female reproductive tract. Fibrinogen-like protein 1 (Fgl-1), an emerging immune checkpoint ligand expressed by tumor cells, mediates immunosuppression by binding to lymphocyte activation gene 3 (Lag-3). However, the clinicopathological significance and oncogenic role of Fgl-1 in EAC remain poorly understood. This study aimed to assess the role of Fgl-1 expression in EAC using immunohistochemistry. The effects of Fgl-1 on viability, migration, and invasion were assessed using the CCK-8 test, cell clone generation, wound healing, and cell migration and invasion assays. A Western blot was used to determine how Fgl-1 affects the outcome of epithelial-mesenchymal transition (EMT)-associated proteins and to investigate the expression of proteins involved in related signaling pathways. Fgl-1 was markedly overexpressed in EAC tissues compared with normal endometrium (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAdenocarcinomaFibrinogenHumansFemaleSignal TransductionCell MovementDisease ProgressionCell Line, TumorEpithelial-Mesenchymal TransitionCell ProliferationMiddle AgedCell Survival

Stichwörter der Autor:innen

Endometrial adenocarcinomaFgl-1PI3K/AKT signaling pathway

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesFibrinogenFGL1 protein, human

Autor:innen und Institutionen

  • Department of Gynecology, Shandong Provincial Third Hospital, Shandong University, Jinan, Shandong, China.
  • Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, China.
  • Department of Obstetrics and Gynecology, Jinan Maternity and Child Care Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Department of Obstetrics and Gynecology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, China. huizhang1218@126.com.

Zitieren

APA

Sun, W., Kong, W., Yu, X., Shang, K., Li, Q., & Zhang, H. (2026). Fgl-1 promotes the progression of endometrial adenocarcinoma through PI3K/AKT signal pathway. Medical Oncology. https://doi.org/10.1007/s12032-026-03375-7

Vancouver

Sun W, Kong W, Yu X, Shang K, Li Q, Zhang H. Fgl-1 promotes the progression of endometrial adenocarcinoma through PI3K/AKT signal pathway. Medical Oncology. 2026. doi:10.1007/s12032-026-03375-7

BibTeX
@article{Sun2026,
  author = {Sun, Wenjing and Kong, Weijia and Yu, Xinyu and Shang, Kaiyue and Li, Qianqian and Zhang, Hui},
  title = {Fgl-1 promotes the progression of endometrial adenocarcinoma through PI3K/AKT signal pathway},
  journal = {Medical Oncology},
  year = {2026},
  doi = {10.1007/s12032-026-03375-7}
}
Kostenlos starten →